Charlie Roco

Charlie cofounded Parse Biosciences and leads as its Chief Technology Officer. He brings a decade of experience in biology-based technology development. He completed his PhD in Bioengineering at the University of Washington, where he was awarded several fellowships from the NIH and the Fred Hutch Cancer Research Center to develop a new scalable approach to sequencing. This work led to multiple publications in Science and the founding of Parse Biosciences. Prior to the University of Washington, he worked at the Wyss Institute at Harvard and University of Pennsylvania in fields of drug delivery and microscopy. He holds a BSE in Biological Systems Engineering from Virginia Tech.